Cancer Treatment Costs and Customs Duty Impact India

The rising cost of cancer treatment in India has become a major concern. Cancer cases increased by 26.4% from 1990 to 2023. Treatment costs are three times higher than for other illnesses. Medicines are the largest expense, especially in rural public hospitals. In 2026, the government proposed full exemption of customs duty on 17 cancer drugs. This move aims to reduce the financial burden on patients.

Cost of Cancer Treatment in India

Cancer treatment costs average ₹61,000 per hospital visit, compared to ₹20,135 for general hospital stays. Private hospitals charge about four times more than public ones. However, the relative cost burden is heavier in public hospitals. In public facilities, cancer treatment costs are five times higher than standard admissions. In rural public hospitals, this multiplier rises to 5.5 times. This shows that poorer and rural patients face greater financial strain.

Trends in Public and Private Hospitals

Between 2014 and 2018, the cost multiplier in private hospitals remained stable at around three times. In public hospitals, it increased from four to five times. Medicine costs form the largest part of expenses in both sectors. In public hospitals, medicines account for 40-50% of total costs. In private hospitals, they make up 20-25%. Doctor fees are low in public hospitals but high in private ones. The customs duty exemption targets medicine costs to ease patient expenses.

Rural-Urban Disparities in Cancer Care Costs

Rural public hospitals show higher cost multipliers than urban ones. The financial burden is heavier for rural patients despite lower overall costs. In private hospitals, cost differences between rural and urban areas are less marked. This suggests that government healthcare needs more support in rural regions to manage cancer treatment costs effectively.

Impact of Customs Duty Exemption

Removing customs duty on 17 cancer drugs reduces import costs. This can lower medicine prices in hospitals. It benefits poorer patients who rely on public healthcare. The policy helps address the growing financial challenge as cancer incidence rises. It also supports the health system’s capacity to provide affordable treatment.

Topics for Prelims:

Cancer Treatment Costs in India

1. Cancer treatment costs are three times higher than average hospitalisation.
2. Medicines form the largest expenditure in cancer care.
3. Public hospitals have a higher cost multiplier than private ones.
4. Rural public hospitals show a 5.5 times cost multiplier for cancer treatment.
5. Private hospital cancer care costs remain consistently high but stable.

Customs Duty Exemption on Cancer Drugs

1. Seventeen cancer-related drugs exempted from basic customs duty.
2. Exemption aims to reduce medicine costs in public and private hospitals.
3. Policy targets easing financial burden on poorer patients.
4. Supports treatment affordability amid rising cancer incidence.
5. Part of government’s health budget reforms in 2026.

Questions for Mains:

1. Discuss in the light of rising healthcare costs how government policies can improve affordability of cancer treatment in India. [GS-III-Economic Development]
2. Critically examine the role of customs duty exemptions in reducing out-of-pocket expenditure on medicines. With suitable examples, discuss their impact on public health. [GS-III-Science & Technology]
3. Explain the rural-urban disparities in healthcare access and costs in India. How can these gaps be bridged to ensure equitable treatment? [GS-I-Indian Society]
4. Comment on the challenges posed by increasing non-communicable diseases like cancer to India’s health system and economic development. Discuss policy measures to address these challenges. [GS-III-Environment & DM]

Answer Hints:

1. Discuss in the light of rising healthcare costs how government policies can improve affordability of cancer treatment in India. [GS-III-Economic Development]

1. Cancer treatment costs are three times higher than average hospitalisation, disproportionately affecting poorer and rural patients.
2. Government interventions like customs duty exemption on cancer drugs help reduce medicine prices, a major cost component.
3. Strengthening public healthcare infrastructure and subsidising cancer care can lower out-of-pocket expenses.
4. Promoting generic medicines and price regulation can improve affordability.
5. Implementing health insurance schemes targeting cancer care can provide financial risk protection.
6. Awareness and early detection programs reduce treatment complexity and overall costs.

2. Critically examine the role of customs duty exemptions in reducing out-of-pocket expenditure on medicines. With suitable examples, discuss their impact on public health. [GS-III-Science & Technology]

1. Customs duty exemption on 17 cancer drugs reduces import costs, directly lowering medicine prices in hospitals.
2. Medicines form 40-50% of cancer treatment costs in public hospitals, so duty cuts ease patient expenses.
3. Exemptions benefit poorer patients reliant on public healthcare, improving access to essential drugs.
4. Lower medicine costs can improve treatment adherence and outcomes, reducing morbidity and mortality.
5. However, impact depends on efficient supply chains and absence of price mark-ups at distribution levels.
6. Similar duty exemptions for other critical drugs can amplify public health benefits and reduce catastrophic health expenditure.

3. Explain the rural-urban disparities in healthcare access and costs in India. How can these gaps be bridged to ensure equitable treatment? [GS-I-Indian Society]

1. In rural public hospitals, cancer treatment costs are 5.5 times higher than standard admissions, higher than urban public hospitals (4.1x).
2. Rural patients face heavier financial burdens despite overall lower absolute costs, indicating poorer affordability and access.
3. Private hospitals show less rural-urban cost disparity but are generally unaffordable for rural poor.
4. Bridging gaps requires strengthening rural healthcare infrastructure, increasing availability of affordable medicines and diagnostics.
5. Expanding government insurance coverage and telemedicine can improve rural access.
6. Community outreach and mobile health units can promote early diagnosis and reduce travel costs.

4. Comment on the challenges posed by increasing non-communicable diseases like cancer to India’s health system and economic development. Discuss policy measures to address these challenges. [GS-III-Environment & DM]

1. Rising cancer incidence (26.4% increase since 1990) strains healthcare resources and increases economic burden on families and system.
2. High treatment costs, especially for medicines, lead to catastrophic health expenditure and impoverishment.
3. Non-communicable diseases (NCDs) require long-term care, increasing demand on public health infrastructure and financing.
4. Policy measures – increase investment in cancer care facilities, subsidise medicines, and implement universal health coverage schemes.
5. Focus on preventive strategies including tobacco control, lifestyle modification, and early screening programs.
6. Strengthen data systems and research to guide evidence-based interventions and resource allocation.